Airway lipoxin A4/formyl peptide receptor 2–lipoxin receptor levels in pediatric patients with severe asthma
- 1 June 2016
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (6) , 1796-1806
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Lipoxin A4 modulates adaptive immunity by decreasing memory B‐cell responses via an ALX/FPR2‐dependent mechanismEuropean Journal of Immunology, 2013
- Lipoxins: resolutionary roadBritish Journal of Pharmacology, 2009
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- Endogenous lipid mediators in the resolution of airway inflammationEuropean Respiratory Journal, 2007
- Dampening inflammationNature Immunology, 2005
- Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T CellsThe Journal of Immunology, 2003
- Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolutionProstaglandins & Other Lipid Mediators, 2002
- Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunityNature Immunology, 2001
- Asthma: From Bronchoconstriction to Airways Inflammation and RemodelingAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical CharacteristicsAmerican Journal of Respiratory and Critical Care Medicine, 1999